These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24909114)

  • 1. Human chimera-type galectin-3: defining the critical tail length for high-affinity glycoprotein/cell surface binding and functional competition with galectin-1 in neuroblastoma cell growth regulation.
    Kopitz J; Vértesy S; André S; Fiedler S; Schnölzer M; Gabius HJ
    Biochimie; 2014 Sep; 104():90-9. PubMed ID: 24909114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells.
    André S; Kaltner H; Lensch M; Russwurm R; Siebert HC; Fallsehr C; Tajkhorshid E; Heck AJ; von Knebel Doeberitz M; Gabius HJ; Kopitz J
    Int J Cancer; 2005 Mar; 114(1):46-57. PubMed ID: 15523676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR.
    Ippel H; Miller MC; Vértesy S; Zheng Y; Cañada FJ; Suylen D; Umemoto K; Romanò C; Hackeng T; Tai G; Leffler H; Kopitz J; André S; Kübler D; Jiménez-Barbero J; Oscarson S; Gabius HJ; Mayo KH
    Glycobiology; 2016 Aug; 26(8):888-903. PubMed ID: 26911284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides derived from human galectin-3 N-terminal tail interact with its carbohydrate recognition domain in a phosphorylation-dependent manner.
    Berbís MÁ; André S; Cañada FJ; Pipkorn R; Ippel H; Mayo KH; Kübler D; Gabius HJ; Jiménez-Barbero J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):126-31. PubMed ID: 24269589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How adhesion/growth-regulatory galectins-1 and -3 attain cell specificity: case study defining their target on neuroblastoma cells (SK-N-MC) and marked affinity regulation by affecting microdomain organization of the membrane.
    Kopitz J; Bergmann M; Gabius HJ
    IUBMB Life; 2010 Aug; 62(8):624-8. PubMed ID: 20665623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary X-ray crystallographic analysis of an engineered variant of human chimera-type galectin-3 with a shortened N-terminal domain.
    Flores-Ibarra A; Ruiz FM; Vértesy S; André S; Gabius HJ; Romero A
    Acta Crystallogr F Struct Biol Commun; 2015 Feb; 71(Pt 2):184-8. PubMed ID: 25664793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Playing Modular Puzzle with Adhesion/Growth-Regulatory Galectins: Design and Testing of a Hybrid to Unravel Structure-Activity Relationships.
    Ludwig AK; Vértesy S; Michalak M; Manning JC; Andre S; Kubler D; Kopitz J; Kaltner H; Gabius HJ
    Protein Pept Lett; 2016; 23(11):1003-1012. PubMed ID: 27697034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the inhibitory potency of galectin ligands identified from combinatorial (glyco)peptide libraries using surface plasmon resonance spectroscopy.
    Maljaars CE; André S; Halkes KM; Gabius HJ; Kamerling JP
    Anal Biochem; 2008 Jul; 378(2):190-6. PubMed ID: 18471425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway.
    Alge-Priglinger CS; André S; Schoeffl H; Kampik A; Strauss RW; Kernt M; Gabius HJ; Priglinger SG
    Biochimie; 2011 Mar; 93(3):477-88. PubMed ID: 21094672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between DMBT1 and galectin 3 is modulated by the structure of the oligosaccharides carried by DMBT1.
    Rossez Y; Coddeville B; Elass E; Quinchon JF; Vidal O; Corfield AP; Gosset P; Lacroix JM; Michalski JC; Robbe-Masselot C
    Biochimie; 2011 Mar; 93(3):593-603. PubMed ID: 21167898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian galectins bind galactoseβ1-4fucose disaccharide, a unique structural component of protostomial N-type glycoproteins.
    Takeuchi T; Tamura M; Nishiyama K; Iwaki J; Hirabayashi J; Takahashi H; Natsugari H; Arata Y; Kasai K
    Biochem Biophys Res Commun; 2013 Jul; 436(3):509-13. PubMed ID: 23751344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer antigen CA125 represents a novel counter receptor for galectin-1.
    Seelenmeyer C; Wegehingel S; Lechner J; Nickel W
    J Cell Sci; 2003 Apr; 116(Pt 7):1305-18. PubMed ID: 12615972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization of a human galectin-3 variant with two ordered segments in the shortened N-terminal tail.
    Flores-Ibarra A; Vértesy S; Medrano FJ; Gabius HJ; Romero A
    Sci Rep; 2018 Jun; 8(1):9835. PubMed ID: 29959397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design-functionality relationships for adhesion/growth-regulatory galectins.
    Ludwig AK; Michalak M; Xiao Q; Gilles U; Medrano FJ; Ma H; FitzGerald FG; Hasley WD; Melendez-Davila A; Liu M; Rahimi K; Kostina NY; Rodriguez-Emmenegger C; Möller M; Lindner I; Kaltner H; Cudic M; Reusch D; Kopitz J; Romero A; Oscarson S; Klein ML; Gabius HJ; Percec V
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2837-2842. PubMed ID: 30718416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human galectin-3 (Mac-2 antigen): defining molecular switches of affinity to natural glycoproteins, structural and dynamic aspects of glycan binding by flexible ligand docking and putative regulatory sequences in the proximal promoter region.
    Krzeminski M; Singh T; André S; Lensch M; Wu AM; Bonvin AM; Gabius HJ
    Biochim Biophys Acta; 2011 Feb; 1810(2):150-61. PubMed ID: 21070836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of protein (human galectin-3) design on aspects of lectin activity.
    García Caballero G; Beckwith D; Shilova NV; Gabba A; Kutzner TJ; Ludwig AK; Manning JC; Kaltner H; Sinowatz F; Cudic M; Bovin NV; Murphy PV; Gabius HJ
    Histochem Cell Biol; 2020 Aug; 154(2):135-153. PubMed ID: 32335744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.
    Iurisci I; Cumashi A; Sherman AA; Tsvetkov YE; Tinari N; Piccolo E; D'Egidio M; Adamo V; Natoli C; Rabinovich GA; Iacobelli S; Nifantiev NE;
    Anticancer Res; 2009 Jan; 29(1):403-10. PubMed ID: 19331179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Galectin-1 in the interaction between chondrocytes and a lactose-modified chitosan.
    Marcon P; Marsich E; Vetere A; Mozetic P; Campa C; Donati I; Vittur F; Gamini A; Paoletti S
    Biomaterials; 2005 Aug; 26(24):4975-84. PubMed ID: 15769533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic binding studies of galectin-1, -3 and -7.
    Brewer CF
    Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.